|
- 2018
玻璃体腔注射雷珠单抗联合内窥镜引导睫状体光凝治疗新生血管性青光眼
|
Abstract:
摘要 目的:研究新生血管性青光眼(NVG)采用玻璃体腔注射雷珠单抗(ranibizumab)联合眼用内窥镜引导睫状体光凝术(ECP)的临床治疗效果.方法: 新生血管性青光眼(NVG)患者26例(36只眼),所有患者均先行玻璃体腔注射雷珠单抗眼用注射液,注药后3~7 d内再行眼用内窥镜下睫状体光凝术,术后进行1~6个月随访,观察包括视力、眼压、术后并发症和降眼压药物的使用等情况.结果: 26例患者(36只眼)中30只眼手术完全成功,3只眼为条件成功,3只眼为失败,手术成功率为91.67%.治疗前患者眼压平均值是(42.49±2.36)mmHg,经过治疗后在不同的时间点其眼压平均值分别为:1周(20.14±5.88)mmHg、1个月(18.81±6.14)mmHg、3个月(18.45±6.05) mmHg、6个月(17.60±6.23) mmHg.治疗之后各个随访时间点测量的眼压值同治疗前眼压值相比较,有统计学差异(P<0.05).少量前房积血、瞳孔区纤维素样渗出及渗出性脉络膜脱离是ECP术后早期出现的并发症,经过对症治疗后均能恢复.结论:采用玻璃体腔注射雷珠单抗联合内窥镜引导行睫状体光凝术治疗新生血管性青光眼(NVG),安全有效.
[1] | SEYMENO R G, ULUSOY M O, BASER E F.Safety and efficacy of panretinal photocoagulation in patients with high-risk proliferative diabetic retinopathy using pattern scan laser versus conventional YAG laser[J].Kaohsiung J Med Sci, 2016,32(1):22-26. |
[2] | KARUS C L,TYCHSEN L,lUEDER G T,et al. Comparison of the effectiveness and safety of transsclearl cyclophotocoagulation in pediatric glaucoma[J].J Pediatr Ophthalmol Strabismus,2004,51(2):120-127. |
[3] | HAVENS S J,GULATI V.Neovascular giaucoma[J].Dev Ophthalmol,2016,55:196-204. |
[4] | YU M B, HUANG S S, GE J, et al.Clinical study of endoscopic cyclophotocoagulation on the of refractory Glaucoma[J].Chin J Ophthalmol,2006,42(1):27-31. |
[5] | CHEN J, COHN R A, LIN S C,et al.Endoscopic photocoagulation of the ciliary body for treatment of refractory glaucoma[J].Am J Ophthalmol.1997,124(6):787-796. |
[6] | SOUIED E H, DUGEL P U,FERREIRA A, et al.Severe ocular inflammation following Ranibizumab or afliberept injections for age-related macular degeneration:a retrospective claims database analysis[J].Ophthalmic Epidemiol,2016,23(2):71-79. |
[7] | YILDIRIM N, YALVAC I S,SAHIN A,et al.A comparative study between diode laser cyclophotocoagulation and the Ahmed glaucoma valve implant in neovascular glaucoma:a long-term follow-up[J]. Glaucoma, 2009,18(3):192-196. |
[8] | YU J Y,KAHOOK M Y,LATHROP,et al.The effect of probe placement and type of viscoelastic material on endoscopic cyclophotocoagulation laser energy transmission[J].Ophthalmic Surg Laser Imaging, 2008,39(2):133-136. |
[9] | SHEN X,CHEN Y W,WANG Y N,et al.Intravitreal ranibizumab imjection as an adjuvant in the treatment of neovascular glaucoma accompanied by vitreous hemorrhage after diabetic vitrectomy[EB/OL]. Journal of Ophthalmology,2016,2016:4108490. |
[10] | 黎铧,胡竹林,朱勤.经睫状体扁平部引流阀植入术治疗复发性新生血管性青光眼的临床研究[J].眼科新进展,2011,31(4):344-346. |
[11] | SOOHOO J R, SEIBOLD L K,KAHOOK M Y.Recent advances in the management of neovascular glaucoma[J].Semin Ophthalmol,2013:28(3):165-172. |
[12] | PARK S C,SU D,TELLO C.Anti-VEGF therapy for the treatment of glaucoma:a focus on ranibizumab and bevacizumab[J].Expert Opin Biol Ther,2012,12(12):1641-1647. |
[13] | BOSCHER C,KUHN F.Endoscopc evaluation and dissention of the anterior vitreous base[J].Ophthalmic Res,2015,53(2):90-99. |
[14] | 杨瑾,孙慧敏,李筱荣,等. 兔眼内窥镜与经巩膜睫状体光凝术的组织病理学特点比较[J].眼科研究,2010,28(1):29-33. |
[15] | SUN Y Y, LIANG Y, ZHOU P,et al.Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term[J].BMC Ophthalmology,2016:16(1):150. |
[16] | LI H, HU Z L, ZHU Q, Clinical study of pars plana drainage valve implantation for recurrent neovascular glaucoma[J].Rec Adv Ophthalmol,2011,31(4):344-346. |
[17] | QIAO B, YAO Y, ZHAO Q Y.Analysis on the factors of neovascular glaucoma after vitrectomy for proliferative diabetic retinopathy[J]. Int J Ophthalmol,2008,8(8):1584-1586. |
[18] | LUKE J, NASSAR K, LUKE M,et al.Ranibizumab as adjuvant in the treatment of rubeosis iridis and neovascular glaucoma—results from a prospective interventional case series[J].Graefes Archive for Clinical and Experimental Ophthalmology,2013,251(10):2403-2413. |
[19] | LI X J, YANG X P, Li Q M,et al.Ranibizumab plus combined surgery for treatment of neovascular glaucoma with vitreous hemorrhage[J].Chinese Medical Journal,2015,128(15):2078-2083. |
[20] | RODRIQUES G B,ABE R Y,ZANQALLI C,et al.Neovascular glaucoma:a review[J].Int J Retinal Vitreous,2016,11(14):2-10. |
[21] | WONG S C,LEE T C,HEIER J S,et al.Endoscopic vitrectomy[J].Curr Opin Ophthalmol,2014:25(3):195-206. |
[22] | YANG J,YANG H M,LI X R,et al.Histopathologic study on endoscopic cyclophotocoagulation and trans-scleral cyclophotocoagulation in rabbit eyes[J]Chinese Ophthalmic Research, 2010,28(1):29-33. |
[23] | 余敏斌,黄圣松,葛坚等.眼内窥镜下睫状体光凝术治疗难治性青光眼的疗效评价[J].中华眼科杂志,2006,42(1):27-31. |
[24] | HOLZ H A, LIM M C.Glaucoma laser: a review of the newer techniques[J].Curr Opin Ophthalmol,2005,16(2):89-93. |